These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19553092)

  • 1. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study.
    Romera I; Perez V; Menchón JM; Delgado-Cohen H; Polavieja P; Gilaberte I
    Eur Psychiatry; 2010 Jan; 25(1):58-65. PubMed ID: 19553092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study.
    Harada E; Satoi Y; Kuga A; Tokuoka H; Kikuchi T; Watanabe K; Alev L; Mimura M
    Neuropsychiatr Dis Treat; 2017; 13():2437-2445. PubMed ID: 29033569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors associated with full remission versus episode of major depressive disorder outpatients: the experience at a teaching hospital in Taiwan.
    Yeh MY; Lee Y; Sung SC; Tung TH
    BMC Psychiatry; 2014 Sep; 14():273. PubMed ID: 25248639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression.
    Harada E; Satoi Y; Kikuchi T; Watanabe K; Alev L; Mimura M
    Neuropsychiatr Dis Treat; 2016; 12():1599-607. PubMed ID: 27418827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study.
    Montoya A; Lebrec J; Keane KM; Fregenal I; Ciudad A; Moríñigo Á; Agüera-Ortiz L; Romera I; Gilaberte I; Zimmerman M
    BMC Psychiatry; 2016 Oct; 16(1):352. PubMed ID: 27760534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of adversity and perceived social support on the outcome of major depressive disorder in subjects with different levels of depressive symptoms.
    Leskelä U; Rytsälä H; Komulainen E; Melartin T; Sokero P; Lestelä-Mielonen P; Isometsä E
    Psychol Med; 2006 Jun; 36(6):779-88. PubMed ID: 16566849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
    Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
    Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of remission status on work functioning in employed patients treated for major depressive disorder.
    Sarfati D; Stewart K; Woo C; Parikh SV; Yatham LN; Lam RW
    Ann Clin Psychiatry; 2017 Feb; 29(1):11-16. PubMed ID: 27901522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
    van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
    J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning.
    Trivedi MH; Corey-Lisle PK; Guo Z; Lennox RD; Pikalov A; Kim E
    Int Clin Psychopharmacol; 2009 May; 24(3):133-8. PubMed ID: 19318972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity among depressed outpatients considered to be in remission.
    Zimmerman M; Posternak MA; Chelminski I
    Compr Psychiatry; 2007; 48(2):113-7. PubMed ID: 17292700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the time to remission on residual symptoms and functioning among depressive patients.
    Zhu XQ; Mayes TL; Qi N; Feng L; Feng Y; Wu WY; Hu YD; Xiao L; Wang G
    J Affect Disord; 2023 Jan; 320():667-673. PubMed ID: 36209781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning.
    Romera I; Pérez V; Menchón JM; Polavieja P; Gilaberte I
    Psychiatry Res; 2011 Mar; 186(1):133-7. PubMed ID: 20659770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: implications for how remission from depression should be defined.
    Zimmerman M; McGlinchey JB; Posternak MA; Friedman M; Boerescu D; Attiullah N
    Psychiatry Res; 2006 Feb; 141(2):185-91. PubMed ID: 16499976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.